NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1700874542 MD
Verify on CMS → Robert Donnell, MD
Hematology & Oncology Physician in Tawas City, Michigan.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,215 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
127
Medicare Part D claims · 19 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
74%
generic claims · 26% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Robert Donnell, MD filed 127 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in Tawas City, Michigan, prescribing 74% generic.
- 127
- Part D claims, 2023
- 74%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Robert Donnell, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
127 35th percentile higher than 35% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
◑
Board-eligible specialty (heuristic, not verified)
Robert Donnell, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Robert Donnell, MD?
Quality data not reportedPrimary specialty
Hematology & Oncology Physician
Medicare Part D claims
127 85% vs specialty avg
Specialty distribution in Michigan
How Hematology & Oncology Physician compares to other specialties among Michigan providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Robert Donnell, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 200 HEMLOCK ST, Tawas City, MI, 48763, with a listed phone of (989) 362-9433. NPI 1700874542 was issued on 10/06/2005.
Medicare Part D records for calendar year 2023 show 127 prescription claims written by this provider, covering 19 Medicare beneficiaries and totaling roughly $650K in drug spend, split 26% brand-name and 74% generic by claim count.
Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1700874542 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 10/06/2005 |
License & disciplinary context - Michigan MI-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 - they are NOT specific to Robert Donnell, MD. To verify Robert Donnell, MD's current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
123
Total board actions, Michigan 2023
Across 120 cases
3.00
Actions per 1,000 licensees
Michigan statewide rate
probation
Most common action type
44 cases
MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Robert Donnell, MD - brand share 26.0%
Hematology & Oncology Physician average
26% brand-name claims vs 74% generic, on 127 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
127
Total Claims
$650K
Total Drug Cost
19
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 177
- Total Day Supply
- 5,098
- Brand vs Generic
- 26% brand / 74% generic
- Brand Drug Cost
- $537K
- Generic Drug Cost
- $113K
Patient Demographics
- Average Patient Age
- 72.6 years
- Avg HCC Risk Score
- 1.33
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Robert Donnell, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Imatinib Mesylate
Imatinib Mesylate
24 claims
- Imbruvica
Imbruvica
24 claims
- Hydroxyurea
Hydroxyurea
22 claims
| Drug | Claims |
|---|---|
| Imatinib Mesylate | 24 |
| Imbruvica Ibrutinib | 24 |
| Hydroxyurea | 22 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Robert Donnell, MD fits within the Hematology & Oncology Physician landscape nationally.
11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider
Robert Donnell, MD's 127 claims are below the specialty average of 847.
Nearby Hematology & Oncology Physician Providers in Michigan
Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as Donnell.
Dr. Ahmed Abdel-Maksoud
MD
Midland, MI
Dr. Jonathan Abramson
M. D.
Bay City, MI
Dr. Calvin Abro
MD
Battle Creek, MI
Lindsey Ackerman
Sterling Heights, MI
Dr. Paul Adams
M.D.
Flint, MI
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Michigan medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Michigan
Frequently Asked Questions
What is Robert Donnell, MD's specialty? ▼
Robert Donnell, MD specializes in Hematology & Oncology Physician and practices in Tawas City, Michigan. Credentials: MD.
How much does Robert Donnell, MD prescribe under Medicare Part D? ▼
In 2023, Robert Donnell, MD wrote 127 Medicare Part D claims totaling $650K in drug costs for 19 beneficiaries.
Where is Robert Donnell, MD located? ▼
Robert Donnell, MD is located at 200 HEMLOCK ST, Tawas City, MI, 48763. Phone: (989) 362-9433.
What is Robert Donnell, MD's NPI number? ▼
Robert Donnell, MD's National Provider Identifier (NPI) is 1700874542, issued on 10/06/2005.
Does Robert Donnell, MD prescribe more brand-name or generic drugs? ▼
Robert Donnell, MD's prescribing is 26% brand-name and 74% generic drugs by claim count, with $537K in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Robert Donnell, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Robert Donnell, MD's most frequently prescribed drugs include Imatinib Mesylate, Imbruvica, Hydroxyurea. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Robert Donnell, MD accept Medicare? ▼
Robert Donnell, MD appears in CMS Medicare data with 127 Part D claims and 19 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Robert Donnell, MD's credentials? ▼
Robert Donnell, MD's NPI is 1700874542 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.